Sunday November 22, 2009 11:36 AM ET
SmartMoney
Net Asset Value: 
18.47
1-Day Return: 
-0.01 (-0.05%)
YTD Return
as of 11/20/09: 
Up 17.64%
PHLAX 
(JennDry Jenn Health;A)
Classification: Health/Biotech     Objective: Health/Biotech
Open to New Investors: Yes
Lipper Rating
Total Return
Consistent Return
Preservation
Tax Efficiency
Expense
The Lipper Leader system ranks a fund in the following categories: Total Return; Consistent Return; Preservation; Tax Efficiency; and Expenses. Funds are rated in ascending order on a numeric scale of 1 to 5, with '1' representing funds with the lowest rating, and '5' representing the highest rated funds and funds that are Lipper Leaders. Click here for more detail.
NAV Chart | Growth of $10,000
Fund Chart
Total Returns (As of 11/20/2009)
 YTD1Yr3Yr5Yr10Yr
Fund 17.64 40.83 -0.12 7.78 11.70
Classification 16.41 37.20 -0.77 3.55 6.13
Index (S&P 500) 23.50 48.80 -5.90 0.70 -0.90
% Rank in Class (1-best,100=worst)42364288
Fund Stats
Investment Objective:Health/Biotech
Net Assets ($Mil)258.00
Inception Date:6/30/99
Manager Name, TenureTeam Managed, NA
Expense Ratio: 1.19%
Sales Charge:
Load Type:
 
Front-End Load
5.50%
0.00%
Top 10 Holdings (As of 8/31/09)
Company NameSymbol% Net Assets
Amag Pharmaceuticals Inc AMAG 4.75
Vertex Pharma VRTX 4.42
Alexion Pharm ALXN 4.10
Shire Plc SHPGY 3.77
Allos Therapeutics Inc ALTH 3.55
Celgene Corp CELG 3.42
Biomarin Pharmaceutical Inc BMRN 3.31
Mylan MYL 3.04
Incyte Corp INCY 2.99
Gilead Sciences Inc GILD 2.96
% of Total Holdings 36.31
Advertisements
View Overview for: